✦ LIBER ✦

Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration

✍ Scribed by Philip J. Rosenfeld; Jeffrey S. Heier; Gary Hantsbarger; Naveed Shams

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review of Ranibizumab Trials for Neovasc

✍ Patel, Ravi D.; Momi, Rominder S.; Hariprasad, Seenu M. 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 601 KB

Safety and Efficacy of a Flexible Dosing

✍ Frank G. Holz; Winfried Amoaku; Juan Donate; Robyn H. Guymer; Ulrich Kellner; Re 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 687 KB

Safety and Efficacy of Conbercept in Neo

✍ Li, Xiaoxin; Xu, Gezhi; Wang, Yusheng; Xu, Xun; Liu, Xiaoling; Tang, Shibo; Zhan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 795 KB

Efficacy and Safety of Monthly versus Qu

✍ Ursula Schmidt-Erfurth; Bora Eldem; Robyn Guymer; Jean-François Korobelnik; Rein 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 985 KB

Impact of Vitreomacular Adhesion on Rani

✍ Waldstein, Sebastian M.; Ritter, Markus; Simader, Christian; Mayr-Sponer, Ulrike 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 797 KB

Measuring the benefit of 4 years of intr

✍ Pushpoth, S.; Sykakis, E.; Merchant, K.; Browning, A. C.; Gupta, R.; Talks, S. J 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 161 KB